NONSMALL CELL LUNG CANCER STAGE III
Clinical trials for NONSMALL CELL LUNG CANCER STAGE III explained in plain language.
Never miss a new study
Get alerted when new NONSMALL CELL LUNG CANCER STAGE III trials appear
Sign up with your email to follow new studies for NONSMALL CELL LUNG CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Race against time: can starting cancer drug sooner save more lives?
Disease control Recruiting nowThis study is testing whether starting an immunotherapy drug called durvalumab sooner after finishing chemotherapy and radiation can better control stage III lung cancer. Researchers want to see if starting treatment within 14 days (instead of the usual longer wait) is safe, effe…
Matched conditions: NONSMALL CELL LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Brain scan strategy aims to head off cancer symptoms
Prevention Recruiting nowThis study is testing whether regular MRI brain scans can help find cancer that has spread to the brain before it causes symptoms in people with stage III non-squamous lung cancer. Researchers want to see if this monitoring approach reduces the number of people who develop neurol…
Matched conditions: NONSMALL CELL LUNG CANCER STAGE III
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Prevention
Last updated Apr 04, 2026 06:51 UTC